CompaniesSpirogen

Spirogen

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

6

By Phase

PHASE1/PHASE2: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
Today
NCT02034227
Hover over trial bars to see details

Recent Trials

NCT02034227Lead Sponsor
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
PHASE1/PHASE2Terminated
6 participants
Started: Apr 30, 2012 · Completed: Jun 30, 2014